Epigral Limited Receives CRISIL AA Stable and A1+ Credit Ratings

Epigral Limited has confirmed total bank loan facilities of Rs 1050 crore. The facilities have been assigned a long-term rating of CRISIL AA/Stable and a short-term rating of CRISIL A1+.

Reader Takeaway: The 'AA' and 'A1+' ratings indicate high safety levels for lenders, bolstering market confidence in company debt.

What just happened

Epigral Limited has formally notified the BSE regarding the latest credit rating assessment conducted by CRISIL Ratings. As of October 28, 2026, the company's cumulative bank loan facilities, totaling Rs 1050 crore, were subjected to a rating review. The agency assigned a long-term rating of CRISIL AA/Stable and a short-term rating of CRISIL A1+.

Why this matters

Credit ratings serve as a vital health check for institutional and retail investors regarding a company's ability to meet its debt obligations. An 'AA' rating indicates a high degree of safety regarding the timely servicing of debt, while an 'A1+' rating is the highest category for short-term debt instruments, signaling very strong liquidity and capacity to meet financial commitments.

What changes now

Following this disclosure, the company remains compliant with Regulation 30 of the SEBI (LODR) Regulations, 2015. The official rationale behind these ratings has been made available by CRISIL on their platform, providing stakeholders with insight into the factors—such as operating performance and financial risk profile—that influenced this assessment.

What to track next

Investors should monitor the company's future debt-to-equity ratios and interest coverage metrics to see how these reflect the stability highlighted by the new rating. The maintenance of these ratings is crucial for the company's cost of borrowing in future financing rounds.